Authors |
Year
|
Title
|
Journal and link to the article
|
Minelli et al.
|
2022 |
Evaluating study designs and treatment outcomes of antidepressant pharmacogenetic clinical trials — challenges and future perspectives. A critical review.
|
European Neuropsychopharmacology
|
Pisanu et al.
|
2022 |
Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic review.
|
European Neuropsychopharmacology
|
Fanelli et al.
|
2022 |
A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response
|
European Neuropsychopharmacology
|
Xicota et al.
|
2022 |
Recommendations for pharmacotranscriptomic profiling of drug response in CNS disorders
|
European Neuropsychopharmacology
|